Ulinastatin shortens the length of ICU stay in critical patients with organ failure: A 7-year real-world study.

Lixue WuDeduo XuYanru LiuWenfang LiWeiwei JiangXia TaoJinyuan ZhangZe YuFei GaoWansheng ChenZhaofen LinYi Shan

Published in: Science progress (2024)

Ulinastatin was beneficial in treating patients in ICU with organ failure, mainly by reducing the length of ICU stay and duration of mechanical ventilation.

Keyphrases

mechanical ventilation
intensive care unit
acute respiratory distress syndrome
end stage renal disease
respiratory failure
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported